231 filings
Page 2 of 12
8-K
fmaez
14 Jun 22
Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
7:01am
8-K
svk4 2ptbrf2t
27 Apr 22
Sio Gene Therapies Provides Corporate Update
4:35pm
8-K
ar20pb
18 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:21pm
8-K
2ucz7prh63 7n5f
11 Feb 22
Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results
7:02am
8-K
90ex70
9 Feb 22
Regulation FD Disclosure
7:00am
8-K/A
l7x9458e 7y9xnz9pi
31 Jan 22
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
rpzrk6we5wy198r50xne
31 Jan 22
Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition
4:08pm
8-K
8mj45j0ijjnc65u gim
25 Jan 22
Departure of Directors or Certain Officers
4:50pm
8-K
lam bchrcj34kaj51z
12 Nov 21
Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial Results
7:02am
8-K
bvuwp
12 Nov 21
Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy Program for Parkinson's Disease
12:00am
8-K
9ddms2eagbcgg2bbrgkz
1 Nov 21
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis
7:00am
8-K
3007s2
21 Oct 21
Departure of Directors or Certain Officers
5:02pm
8-K
a5n3vu5teeoo3
21 Oct 21
Regulation FD Disclosure
6:02am
S-8
usyr44r41 cxiu4
6 Oct 21
Registration of securities for employees
5:18pm
8-K
iaqg3govhpb6wrek
24 Sep 21
Departure of Directors or Certain Officers
4:09pm
8-K
v7r au3pz9lj4a90bc
12 Aug 21
Sio Gene Therapies Announces Corporate Updates and Fiscal First Quarter 2021 Financial Results
7:22am